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Abstract
Parasitic nematodes are of medical and veterinary importance, adversely affecting human health and animal welfare. Ascaris
suum is a gastrointestinal parasite of pigs; in addition to its veterinary significance it is a good model of the human parasite
Ascaris lumbricoides, estimated to infect ,1.4 billion people globally. Anthelmintic drugs are essential to control nematode
parasites, and nicotinic acetylcholine receptors (nAChRs) on nerve and muscle are the targets of cholinergic anthelmintics
such as levamisole and pyrantel. Previous genetic analyses of nematode nAChRs have been confined to Caenorhabditis
elegans, which is phylogenetically distinct from Ascaris spp. and many other important parasites. Here we report the cloning
and expression of two nAChR subunit cDNAs from A. suum. The subunits are very similar in sequence to C. elegans UNC-29
and UNC-38, are expressed on muscle cells and can be expressed robustly in Xenopus oocytes to form acetylcholine-,
nicotine-, levamisole- and pyrantel-sensitive channels. We also demonstrate that changing the stoichiometry of the receptor
by injecting different ratios of the subunit cRNAs can reproduce two of the three pharmacological subtypes of nAChR
present in A. suum muscle cells. When the ratio was 5:1 (Asu-unc-38:Asu-unc-29), nicotine was a full agonist and levamisole
was a partial agonist, and oocytes responded to oxantel, but not pyrantel. At the reverse ratio (1:5 Asu-unc-38:Asu-unc-29),
levamisole was a full agonist and nicotine was a partial agonist, and the oocytes responded to pyrantel, but not oxantel.
These results represent the first in vitro expression of any parasitic nicotinic receptor and show that their properties are
substantially different from those of C. elegans. The results also show that changing the expression level of a single receptor
subunit dramatically altered the efficacy of some anthelmintic drugs. In vitro expression of these subunits may permit the
development of parasite-specific screens for future anthelmintics.
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Introduction
Nematodes of the genus Ascaris are large (,30 cm) gastrointes-
tinal parasites of swine (Ascaris suum) and humans (Ascaris
lumbricoides). Ascaris lumbricoides infects ,1.4 billion people globally,
and is particularly prevalent in conditions of poor sanitation and
poverty [1,2]. In addition to directly causing morbidity (such as
malnutrition) and mortality (via obstruction of the gut or bile duct),
A. lumbricoides infection also exacerbates other diseases prevalent in
impoverished communities such as malaria, tuberculosis and
AIDS [3,4]. Ascaris suum is a major parasite of pigs, causing serious
economic losses for farmers [5]. It could also be considered as a
good model of the human parasite and in some cases may infect
humans directly as a zoonosis [6,7].
At present, control of helminth infections in both animals and
humans relies on administration of anthelmintic chemotherapeutic
agents. The nematode nicotinic acetylcholine receptors (nAChRs)
on muscle are the target of the cholinergic anthelmintics
levamisole, pyrantel and oxantel; such compounds cause these
ligand-gated ion channels to open, leading to prolonged muscle
contraction and spastic paralysis of the parasite [8]. The
importance of nematode nAChR as drug targets has been
underlined by the recent announcement of a new class of
cholinergic anthelmintics, the amino-acetonitrile derivatives,
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though these do not seem to act on muscle nicotinic receptors [9].
The relative ease with which the large muscle cells of A. suum can
be manipulated has permitted electrophysiological characterisa-
tion of the native nAChRs. This has shown that 3 distinct
pharmacological nAChR subtypes are present on Ascaris muscle
cells, with different agonist and antagonist sensitivities: an L-
subtype most sensitive to the agonists levamisole and pyrantel, an
N-subtype most sensitive to nicotine, oxantel and methyridine, and
a B-subtype most sensitive to bephenium [10–12]. Nicotine- and
levamisole-sensitive nAChR have also been identified in the model
nematode C. elegans, where the genes unc-38, unc-29, unc-63, lev-1
and lev-8 encode nAChR subunits involved in levamisole
sensitivity [13]. Heterologous expression of unc-38, unc-29 and
lev-1 in the Xenopus oocyte system produces a functional levamisole-
sensitive nAChR, but the currents have a small amplitude
suggesting the need for additional components [14–16]. Recently
Boulin et al [17] have reported that eight gene products, the five
receptor subunits and three ancillary proteins (RIC-3, UNC-50
and UNC-74) are required to reconstruct the L-type receptor from
C. elegans. This receptor is completely insensitive to nicotine, but
nicotine-sensitive receptors are present in C. elegans and are formed
by a pentamer of ACR-16 subunits, which express robustly in
Xenopus oocytes [18]. However, Ascaris spp. and several other
medically important parasites (for instance Brugia malayi and
Onchocerca volvulus, which cause lymphatic filariasis and river
blindness) belong to a phylogenetic group (clade III) which is only
distantly related to C. elegans, which is a member of clade V [19].
We have previously reported that many nAChR subunit genes
found in C. elegans are absent from the B. malayi genome [20]. Of
particular relevance is the absence of sequences similar to the
nAChR subunit genes lev-1 and lev-8, which encode subunits of the
C. elegans L-type receptor, and a greatly reduced number of genes
encoding subunits similar to ACR-16, which makes up the N-type
receptor [21]. This analysis suggests that the subunit composition
of the L- and N-type nicotinic receptors may be quite different in
the pathogenic clade III nematodes from that found in C. elegans.
However, there have been very few molecular studies on parasitic
nematode nicotinic receptors, and their subunit composition has
not been determined to date.
We have therefore been following up this bioinformatic analysis
with molecular studies, with the intention of recapitulating the L-
and N-subtypes of the A. suum nAChR in vitro. Here we report the
identification of A. suum orthologues of unc-38 and unc-29, and
confirm, using antibody labelling, their presence and co-localisa-
tion in A. suum muscle cells. When expressed in Xenopus oocytes
they form functional levamisole-sensitive nAChR. By altering the
ratio at which the two cRNAs encoding these subunits are injected
into the oocytes, receptors with different pharmacological profiles
can be produced that respond to different nicotinic anthelmintics.
The pharmacology of these receptors resembles the L- and N-
subtypes present in native A. suum muscle cells.
Results
Cloning and antibody labelling
In order to obtain cDNAs encoding nicotinic receptor subunits
from A. suum, we first aligned the amino-acid sequence of the C.
elegans UNC-38 and UNC-29 subunits with their predicted
orthologues from B. malayi. A partial cDNA sequence from A.
suum similar to C. elegans unc-38 was found in the database
(Accession number AJ011382) and used to design specific primers
to extend the sequence. Degenerate primers based on well
conserved regions of amino-acid sequence were used to amplify
a partial cDNA clone of the unc-29-like gene from A. suum
(Figure 1). 59 and 39 RACE procedures [22] were then used to
obtain the remainder of the sequences. Full-length cDNAs
encoding the A. suum orthologues of unc-38 and unc-29 were then
amplified using primers specific for the 59 and 39 termini, cloned,
sequenced and deposited in GenBank with the accession numbers
EU053155 and EU006073. The predicted sequences of the
subunits, designated Asu-UNC-29 and Asu-UNC-38 (using the
nomenclature proposed in http://www.wormbase.org/wiki/index.
php/UserGuide:Nomenclature_nematode) are shown in Figure 1,
together with an alignment with the C. elegans and predicted B.
malayi subunits. The residues within the predicted loops that make
up the ligand-binding site [23], predicted signal peptide and
transmembrane domains, and the residues predicted to confer
cation specificity on the ion channel are highlighted. The
sequences predict that Asu-UNC-38 is an a subunit, since it
contains the typical Y-X(X)-CC ACh binding motif (residues
185–190) in loop C of the ligand-binding site, whereas Asu-UNC-
29, lacking this motif, has all the characteristics of a non-a
subunit, with complementary binding residues. Asu-UNC-38, like
its C. elegans equivalent, also possesses the amino-acid residues
reported to be necessary for activation by levamisole at positions
153 (glutamate) and 191 (proline) of the mature polypeptide [24].
The designation of these subunits as the A. suum equivalents of
UNC-29 and UNC-38 is based on the results of BLASTP
searches and pair-wise sequence comparisons with the C. elegans
nicotinic receptor subunits (Table 1).
If Asu-UNC-29 and Asu-UNC-38 are components of the A.
suum L- or N-type nicotinic receptors, they should be expressed on
muscle cells. We therefore raised specific anti-subunit antibodies,
using synthetic peptides from the N-terminal region of the
predicted mature subunits as immunogens (Figure 1). The
resultant antibodies were purified by affinity chromatography
and used to perform indirect immunofluorescence on whole
muscle cells obtained by collagenase treatment of A. suum. The
anatomy of Ascaris spp. muscle cells and neuromuscular junctions is
somewhat different from that of mammals [25], in that the muscle
cells send out processes, muscle arms, which make contact with the
neurons within the nerve cord; the neuromuscular junctions are
thus at the ends of the muscle arms. Figure 2A shows that the anti-
Author Summary
Ascarid nematodes are major pathogens of humans and
livestock. The major method of control is by the use of
anthelmintic drugs, many of which target the nervous
system. Drugs such as levamisole, pyrantel and oxantel
target the nicotinic acetylcholine receptors present on
muscle. Nematodes have several such receptors, and until
now these have been best understood in the model
species Caenorhabditis elegans. We have started to
characterise the nicotinic receptors of Ascaris suum, and
find that the genetics and pharmacology of the A. suum
receptors differ from C. elegans. In both species, nicotine
and levamisole preferentially activate different forms of
the nicotinic receptor, the N- and L-type, respectively. In C.
elegans, the L-type receptor is made up of five subunits,
whereas the N-type is a homomer of a sixth subunit. We
can recapitulate many of the properties of the A. suum N-
and L-type receptors, including their sensitivity to two
other important anthelmintics, pyrantel and oxantel, by
expressing just two subunits at varying ratios. This has
implications for the use of drug combinations and for
cross-resistance between nicotinic anthelmintics. It may
start to give an explanation for the varying effectiveness of
nicotinic drugs against different parasites.
Nicotinic Receptors of Ascaris suum
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Asu-UNC-38 antibody labelled the whole surface of isolated
muscle cells, including the muscle arms (indicated by arrow A), the
bag region, which is used in the preparation of the patches used in
the single channel recordings [10–12], and spindle which is the
contractile region. The same antibody also labelled portions of the
nerve cord (Figure 2B) and portions of the muscle arms that had
remained attached to the cord during sample preparation.
Antibodies against both subunits labelled the muscle cell
membrane in the muscle arm region which leads from the muscle
cell to the nerve to form the neuromuscular junction (Figure 2C).
The antibody labelling also showed that the expression of the two
subunits overlapped, suggesting they may be components of the
same receptor. All of these results are consistent with these two
subunits being components of a muscle receptor, which is
expressed extra-synaptically and synaptically at the neuromuscular
junction.
Co-expression of Asu-UNC-38 and Asu-UNC-29 produces
functional heteromeric nAChRs
Since the two subunits seemed to co-localise on muscle cells and
may thus be predicted to co-assemble in the same receptors, we
injected cRNAs encoding the two polypeptides into Xenopus
oocytes. Two-electrode voltage clamp experiments showed that
Asu-UNC-38 and Asu-UNC-29 formed a heteromeric receptor
when expressed in these cells. The results are shown in Figure 3:
injection of neither cRNA produced functional receptors when
injected into Xenopus oocytes alone, but when equal amounts of
cRNAs encoding both subunits were injected, functional nAChRs
were produced which gave a robust (,800 nA) response to
100 mM acetylcholine (Ach). The receptors also responded to
100 mM levamisole and 100 mM nicotine, and all of these
responses could be reversibly blocked by application of 10 mM
mecamylamine, a broad-spectrum antagonist of nAChRs known
to inhibit ACh-induced contraction of Ascaris muscle [26]
(Figure 3). Dose-response relationships were established for
acetylcholine, nicotine and levamisole, and all responses normal-
ised to the response to 100 mM ACh. Sigmoidal dose-response
curves were fitted to the data using GraphPad Prism software
(Figure 3C), and show that the order of agonist efficacy is
levamisole.ACh.nicotine (Table 2), consistent with earlier
voltage-clamp observations on native A. suum muscle tissue
[8,26]. The dose-response curves were rather shallow, with
estimated Hill numbers of 0.63 for acetylcholine, 0.64 for
levamisole and 0.77 for nicotine. Two explanations seemed
possible; either the receptors showed negative co-operativity,
which would be unusual for nicotinic receptors, or a mixed
population of receptors, with differing EC50 for the agonists, was
being produced. There is precedence for the second explanation
from studies on mammalian neuronal nicotinic receptors com-
posed of a4b2 subunits [27,28].
Changing the subunit stoichiometry of the receptor
changes its pharmacological properties
The pentameric nature of the nAChR implies that when two
cRNAs encoding different subunits are injected into oocytes at an
equimolar ratio, a mixed population of receptors is likely to be
produced (potentially (Asu-UNC-38)5, (Asu-UNC-38)4:(Asu-UNC-
29)1, (Asu-UNC-38)3:(Asu-UNC-29)2, (Asu-UNC-38)2:(AsuUNC-
29)3, (UNC-38)1:(UNC-29)4 , (UNC-38)0:(UNC-29)5). We have
already shown that molecules containing the subunits in the ratios
5:0 and 0:5 Asu-UNC-38:Asu-UNC-29 do not form functional
receptors (Figure 3A). The shallow slope of the dose-response
relationships recorded in Figure 3C is also suggestive of a mixed
population of receptors. In order to resolve this, we varied the ratio
at which the Asu-unc-38 and Asu-unc-29 cRNAs were injected into
the oocytes. Based on data from the mammalian neuronal
nAChRs, this should cause the formation of a population of
receptors with predominantly (UNC38)3:(UNC29)2, (UN-
C38)2:(UNC29)3 stoichiometries. Oocytes injected with the two
cRNAs at ratios of 10:1 and 1:10 produced only very small
currents in response to acetylcholine, but injection at ratios of 5:1
and 1:5 resulted in robust currents in response to agonist. Injection
of the cRNAs in both ratios (5:1 and 1:5) produced receptors with
comparable responses to ACh, but a striking difference in the
agonist efficacy of levamisole and nicotine was observed between
the two ratios (Table 2). Figure 4 shows the dose-response
relationships for levamisole and nicotine (normalised to the
response to 100 mM ACh) for the 5:1 and 1:5 (Asu-unc38:Asu-unc-
29) cRNA ratio experiments. When the ratio was 5:1 Asu-unc-
38:Asu-unc-29 nicotine was a full agonist, whereas levamisole was
only a partial agonist, with a maximal response of only 60% of that
of ACh (Table 2). When cRNAs at a ratio of 1:5 Asu-unc-38:Asu-
Table 1. Comparison of the amino-acid sequences of A. suum nicotinic receptor subunits with those of C. elegans.
C. elegans polypeptides in order of
identity to Ascaris suum UNC-38 Percentage identity
C. elegans polypeptides in order of
identity to Ascaris suum UNC-29
Percentage
identity
UNC-38 80 UNC-29 77
UNC-63 53 LEV-1 62
ACR-12 38 ACR-3 55
ACR-8 40 ACR-2 49
ACR-6 36 UNC-63 37
The best hits from a BLASTP search are shown.
doi:10.1371/journal.ppat.1000517.t001
Figure 1. The translated sequence of Asu-UNC-29 and Asu-UNC-38 aligned with the C. elegans and B. malayi equivalents (UNC-29
only). In panel A), the conserved regions used in the design of the degenerate oligonucleotides are highlighted in blue. For both panels, the
predicted signal peptide is in lower case, the transmembrane regions are highlighted in yellow, the ligand binding residues [39] in red, the glutamic
acid and aspartic acid residues conferring cation specificity to the ion channel [40] are in highlighted in green. The N-terminal subunit-specific
peptides used to raise antisera are highlighted in black. In panel B), the amino-acid residues identified by Rayes et al [24] as essential for levamisole
activation are highlighted in purple.
doi:10.1371/journal.ppat.1000517.g001
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unc-29 were used, levamisole was now a full agonist (with a
maximal response of 130% of that of ACh), and nicotine was now
only a partial agonist with a maximal response of only 45%
(Table 2).
Additional experiments were performed to further characterise
the pharmacology of the different receptors produced using 5:1
and 1:5 ratios of Asu-unc-38:Asu-unc-29 cRNAs. Pyrantel and
oxantel, in addition to their respective specificity for the L- and N-
subtypes native nAChR found in A. suum [11], are anthelmintic
compounds of medical and veterinary importance. The dose-
response relationships observed using these compounds were more
complex than observed for the other agonists as both oxantel and
pyrantel are known to be agonists of native A. suum nAChRs at
lower concentrations, but open channel blockers at higher
concentrations, producing an asymmetric bell-shaped dose-
response relationship [8,29]. The results for these experiments
are shown in Figure 5, and show dramatic differences in agonist
efficacy between the receptors with different stoichiometries. The
oocytes injected with a 5:1 ratio of Asu-unc-38:Asu-unc-29 cRNAs
responded to oxantel, giving a maximal response at ,10 mM, but
gave very little response to pyrantel. The oocytes injected with a
1:5 ratio of Asu-unc-38:Asu-unc-29 cRNAs were more sensitive to
pyrantel, giving a maximal response at ,1 mM, but gave a
negligible response to oxantel. Maximal responses in both cases
were comparable to the maximal response to ACh (Table 2),
though the steep nature of the dose-response curves suggests that
full agonist activity was not reached before the channel blocking
action began to affect response size. The specificity of levamisole
and pyrantel for the receptor population formed from a 1:5 Asu-
unc-38:Asu-unc-29 cRNA ratio matches the pharmacological
properties of the native A. suum L-subtype nAChR, whereas the
specificity of nicotine and oxantel for the receptor population
Figure 2. Immunolocalisation of nAChR subunits in isolated A. suum muscle cells. A) Confocal microscope images showing indirect
immunofluorescent labelling of Ascaris suum muscle with primary antibody against Asu-UNC-38 and FITC conjugated secondary antibody. A whole
muscle cell is shown, with Asu-UNC-38 localised to the cell membrane over the entire cell surface. Arrow A indicates the muscle cell arm, B the bag
region of the cell, and C the contractile region. B) Asu-UNC-38 localised to the muscle arms where contact with the nerve cord is made to form the
neuromuscular junction (indicated by arrows). No labelling of the nerve cord itself was observed. C) Co-localisation of Asu-UNC-29 and Asu-UNC-38
on the muscle cell arm (region A in panel A).
doi:10.1371/journal.ppat.1000517.g002
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formed following injection of a 5:1 cRNA ratio resembles the
pharmacology of the N-subtype nAChR.
Discussion
The generation of functional levamisole-sensitive nAChRs using
the A. suum orthologues of UNC-38 and UNC-29 shows that, as in
C. elegans, these subunits are likely to be components of the native
levamisole-sensitive nAChR [15]. However there are clear and
striking differences between the two species in terms of the number
of gene products that need to be expressed in order to reconstitute
a robust levamisole response. In C. elegans, 3 other nAChR subunits
and three ancillary proteins are necessary for the full levamisole
response: LEV-1, LEV-8, UNC-63, RIC-3, UNC-50 and UNC-
Figure 3. Two-electrode voltage clamp electrophysiological experiments on Xenopus oocytes. A) Oocytes injected with Asu- unc-38 or
Asu-unc-29 cRNAs alone produced no functional receptors, whereas oocytes injected with both subunit cRNAs in an equimolar ratio gave robust
responses to application of 100 mM acetylcholine (ACh). B) Oocytes injected with an equimolar ratio of Asu-unc-38 and Asu-unc-29 cRNA responded to
100 mM acetylcholine (ACh), 100 mM levamisole (lev) and 100 mM nicotine (nic). These responses could all be reversibly blocked by application of
10 mM mecamylamine. C) Dose-response relationships for the agonists levamisole (lev, grey circles), acetylcholine (ACh, black diamonds) and nicotine
(nic, black triangles) from oocytes injected with an equimolar ratio of Asu-unc-38 and Asu-unc-29. Responses are all normalized to the response to
100 mM acetylcholine. N= 3 (where N is batches of oocytes) and n= 6 (where n is the number of individual oocytes) minimum for each data point.
doi:10.1371/journal.ppat.1000517.g003
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74 [17]. We have previously shown using a bioinformatic
approach and the genome of B. malayi, a parasite closely related
to A. suum, that lev-1 and lev-8 are apparently absent from this
group of nematodes; however a sequence related to unc-63 is
apparently present in B. malayi [21], though its function is
currently unknown. In addition, Asu-UNC-29 and Asu-UNC-38
form nicotine-sensitive receptors. In C. elegans nicotine sensitivity is
conferred by ACR-16 subunit-containing receptors [18], and the
levamisole-sensitive receptor is completely insensitive to nicotine
[17]. We have so far been unable to identify any sequences clearly
orthologous to acr-16 in A. suum or B. malayi [21], though it is
possible that other nAChR subunits may fulfil an analogous
function in the parasites: in C. elegans acr-16 belongs to a fairly large
sub-family of nAChR subunit genes [30], and the other parasite
genomes seem to possess at least one member of this sub-family
[21]. These results demonstrate very clear and marked differences
between the nAChR of C. elegans and an important parasite and
emphasise the importance of studying anthelmintic receptors in
target species in addition to model organisms. They also raise the
possibility that parasite-specific screens for novel cholinergic
anthelmintics could be developed via the expression of the
parasite receptor subunits.
The two subunit sequences possessed all of the features we
would expect from functional equivalents of C. elegans UNC-38 and
UNC-29, including the amino-acids thought to confer sensitivity to
low concentrations of levamisole [24]. Immunoflourescence
labelling of isolated A. suum muscle cells and nerve cords supported
the proposal that the two subunits are expressed on muscle cells,
including the neuromuscular junction. Nicotinic receptors in A.
suum muscle, unlike those in C. elegans, are not clustered solely at
the neuromuscular junction, but are present all over the cell
membrane, as shown both in Figure 2 and by the fact that it is
possible to make single-channel and intracellular recordings from
the bag region of the cell [10–12,31].
We could express cRNAs encoding the two A. suum subunits in
Xenopus oocytes to form receptors with many of the properties
reported for the muscle nicotinic receptors; they were sensitive to
aceylcholine, levamisole and nicotine. However, injection of the
two subunit cRNAs into the oocytes at different ratios generated
distinct receptor populations. This effect was more obvious when
ratios of 1:5 and 5:1 (Asu-unc-38:Asu-unc-29) were injected;
injection of the two cRNAs at ratios of 1:10 and 10:1 produced
very small currents which were impossible to study further.
Though several different populations could theoretically be
generated in these experiments [32] (Figure 6), previous data
from the mammalian a4b2 nAChR suggests that the most likely
combinations of two subunits to yield functional receptors will be
in the ratios 2:3 and 3:2 [27,28,33] and this is supported by our
difficulty in producing robust responses when injecting at a ratio of
10:1, which would theoretically produce more receptors of a 4:1
than 3:2 subunit stoichiometry. If the pharmacology of A. suum
nAChRs can be altered simply by generating different combina-
tions of two subunits, this may help to explain how sufficient
pharmacological and neurological complexity can be found in
parasites with remarkably few nAChR genes compared to C.
elegans. Pharmacological diversity generated by alternate stoichi-
ometries has not previously been observed in invertebrates, but is
well described for heterologous expression of the mammalian
neuronal nAChR subunits a4 and b2. Receptors with the
stoichiometry (a4)3(b2)2 have lower agonist affinity and a different
pharmacological profile to receptors with the stoichiometry
(a4)2(b2)3, and addition of an accessory subunit to give (for
example) an (a4)2(b2)2(a5) combination confers additional phar-
macological differences [27,28,33]. In extrapolating the mamma-
lian a4b2 model to interpret the results presented here, we suggest
that we have generated receptor subtypes that have the
stoichiometry (Asu-UNC-38)2(Asu-UNC-29)3, and (Asu-UNC-38)3
(Asu-UNC-29)2.
If our results are compared with those obtained from single
channel recordings on A. suum muscle [11–13], our data are
consistent with a suggestion that (Asu-UNC-38)2(Asu-UNC-29)3
constitutes the L-subtype nAChR and that (Asu-UNC-38)3(Asu-
UNC-29)2 forms the N-subtype. The complex mixture of receptors
present in the in vivo preparation makes a quantitative comparison
with our in vitro data difficult, but there are clear qualitative
similarities. The L-subtype of the native receptor is preferentially
activated by levamisole, though nicotine does also open L-type
channels, and vice versa for the N-subtype; our oocyte data show
that nicotine is only a partial agonist at the putative (Asu-UNC-
38)2(Asu-UNC-29)3 receptor and levamisole is, similarly, only a
Table 2. Summary of the properties of the receptors formed after injection of Asu-unc-38 and Asu-unc-29 cRNAs at different ratios.
Agonist
1:1
Asu-unc-38:
Asu-unc-29
1:5
Asu-unc-38:
Asu-unc-29
5:1
Asu-unc-38:
Asu-unc-29
Body wall muscle
contraction.
Data from [11]
Acetylcholine Not selective Imax 1.00 0.8860.05 0.9560.15
pEC50 4.9760.16 5.9560.12 6.1460.12 ND
Levamisole L-subtype selective Imax 1.3060.15 1.3060.16 0.5960.58
pEC50 4.7860.25 5.5360.37 5.6260.49 5.8360.03
Pyrantel L-subtype selective Imax ND 1.0360.27 *
pEC50 ND 6.4060.18 * 7.2460.03
Nicotine N-subtype selective Imax 0.7160.07 0.4660.12 1.0960.29
pEC50 4.7960.22 5.8860.95 5.5761.56 4.8560.05
Oxantel N-subtype selective Imax ND * 1.4460.88
pEC50 ND * 5.3961.06 7.1860.02
The relative maximal currents (Imax) have been normalized to those elicited by acetylcholine on oocytes injected with a 1:1 ratio of the two cRNAs, due to the large
variations in current size seen between individual oocytes. The acetylcholine maximal currents were up to 800 nA to 2 mA. Responses from each oocyte were
normalized to 100 mM acetylcholine. ND=Not determined. Results are shown as the mean6S.E., N =minimum of 3. * Due to the small size of the responses seen, it was
not possible to derive any quantitative measurements for this receptor:agonist combination.
doi:10.1371/journal.ppat.1000517.t002
Nicotinic Receptors of Ascaris suum
PLoS Pathogens | www.plospathogens.org 7 July 2009 | Volume 5 | Issue 7 | e1000517
partial agonist at the putative (Asu-UNC-38)3(Asu-UNC-29)2
receptor. There are also clear similarities in the effects of the
anthelmintics, pyrantel and oxantel, between our results and the
single channel measurements; pyrantel acts at the same sub-type
that levamisole prefers and oxantel at the one preferred by
nicotine. We believe, therefore, that we have recapitulated many
of the properties of the L- and N-subtypes by varying the
expression levels of the two A. suum subunits within the oocyte
system. These results have important implications for the
development and management of parasite resistance to cholinergic
anthelmintics; it has previously been assumed that parasites
resistant to levamisole or pyrantel may still be susceptible to
oxantel as different receptor sub-types are involved [11], but if
both receptor types contain the same subunits, then the potential
for development of resistance to both classes of cholinergic
anthelmintic is greater. Kopp et al [34] have recently reported
changes in the expression of hookworm nicotinic receptor subunit
mRNAs that may be associated with pyrantel resistance.
An important open question concerns the function of the A. suum
UNC-63 subunit. Despite exhaustive efforts, so far we have been
Figure 4. Levamisole and nicotine responses from oocytes injected with cRNAs at 5:1 and 1:5 ratios. A) Levamisole and nicotine
responses from oocytes injected with a 1:5 ratio of Asu-unc-38 and Asu-unc-29. The currents evoked by levamisole application are larger than those
produced by nicotine application. Agonist application is indicated by a bar above the trace, and the concentrations are indicated in mM. The dose-
response relationships for levamisole and nicotine are derived from N=3 n= 6 minimum for each data point, where n = number of oocytes tested,
N =number of frogs from which the oocytes were obtained. Levamisole acts as a full agonist on this receptor subtype, whereas nicotine acts as a
partial agonist. All responses were normalized to the response to 100 mM acetylcholine: an example of such a response is shown as the inset. B)
Nicotine and levamisole responses from oocytes injected with a 5:1 Asu-unc-38:Asu- unc-29 ratio. The currents evoked by nicotine application are
larger than those produced by levamisole application. Agonist application is indicated by a bar above the trace, concentrations are given in mM. The
dose-response relationships for levamisole and nicotine, where N=3 n=6 minimum for each data point. Nicotine acts as a full agonist on this
receptor subtype, whereas levamisole acts as a partial agonist. All responses were normalized to the response to 100 mM acetylcholine, an example of
which is shown.
doi:10.1371/journal.ppat.1000517.g004
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unable to generate a cDNA clone encoding an obviously full-length
UNC-63 subunit. This may be due to purely technical difficulties, or
it may that, in A. suum, unc-63 encodes only a truncated mRNA. It is
tempting to speculate that the B-subtype nAChR has the
composition (Asu-UNC-38)2(Asu-UNC-29)2(Asu-UNC-63)1, by
analogy with the (a4)2(b2)2(a5)1 receptors found in mammals [33],
but we have no direct evidence to support this speculation.
In summary, we have demonstrated that the A. suum
homologues of UNC-38 and UNC-29 co-express in Xenopus
oocytes to form a functional nAChR, which is the first successful
expression in vitro of a nAChR from parasitic nematodes. This will
create opportunities for future work to be performed, where for
the first time candidate drug resistance mutations in parasite
nAChR subunits can be assessed directly for their effect on
Figure 5. Responses to the anthelmintics pyrantel and oxantel. A) Electrophysiological recording from an oocyte injected with a 1:5 Asu-unc-
38:Asu-unc-29 ratio in response to the application of pyrantel (upper trace) and oxantel (lower trace). Pyrantel clearly acts as an agonist at lower
concentrations (,1 mM) and a channel block effect reduces the response seen at higher concentrations; in comparison to this oxantel only produced
small currents at any concentration. Agonist application is indicated by a bar above the trace and the concentrations are given in mM. The dose-
response relationships for pyrantel and oxantel from oocytes injected with a 1:5 ratio of Asu-unc-38 and Asu-unc-29 are shown: N= 3 n=6 minimum
for each data point. All responses were normalized to the maximal response (i.e. to the response to 1 mM pyrantel), which was comparable to the
response to 100 mM acetylcholine (not shown). B) Electrophysiological recording from oocytes injected with a 5:1 Asu-unc-38:Asu-_unc-29 ratio in
response to the application of oxantel (upper trace) and pyrantel (lower trace). Oxantel clearly acts as an agonist at lower concentrations (,10 mM)
and a channel block effect reduces the response seen at higher concentrations; in comparison to this pyrantel only produced small currents at any
concentration. Agonist application is indicated by a bar above the trace. Agonist concentrations and the concentrations are given in mM. The Dose-
response relationships for pyrantel and oxantel from oocytes injected with a 5:1 ratio of Asu-unc-38 and Asu-unc-29 are based on N= 3 n= 6 minimum
for each data point. All responses were normalized to the maximal response (i.e. to the response to 10 mM oxantel), which was comparable to the
response to 100 mM acetylcholine (not shown).
doi:10.1371/journal.ppat.1000517.g005
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anthelmintic efficacy and receptor function. This work also paves
the way to an accelerated understanding of anthelmintic drug
targets and the potential development of parasite-specific target-
based screens for new compounds.
Materials and Methods
Ethics statement
All animals used for production of antisera were handled in
strict accordance with good animal practice and the conditions
defined by the United Kingdom Home Office (Harlan, UK) or the
United States Department of Agriculture (Sigma Genosys).
Molecular biology
Partial sequences of Ascaris suum unc-38 and unc-29 were
amplified using primers designed on a partial sequence of Asu-
unc-38 present in GenBank (AJ011382) (Primer sequences
GTCGCGCTTACCGTTTTCTTCC and CCATCGCCACA-
TATTTCCAGTCTT) and using degenerate primers based on an
alignment of the unc-29 sequences from C. elegans and Brugia malayi
(primer sequences ATCAAYGTNGAYGARAARGAYCA and
ATYTCRTTYTCRTTRTANGTCCA). The sequences were
extended to full length using 59 and 39 RACE [22]. For 59
RACE, an oligonucleotide corresponding to the spliced leader,
SL1 (GGTTTAATTACCCAAGTTTGAG) was used in conjunc-
tion with specific internal primers (Asu-unc38 TAAAGCACGCT-
GACACCACC; Asu-unc-29 ATYTCRTTYTCRTTRTANG-
TCCA). For 39 RACE an ‘anchor’ primer sequence incorporated
into the oligo(dT) primer used for reverse transcription (GAC-
CACGCGTATCGATGTCGAC) was together with an internal
primer specific for Asu-unc-29 (GCACTAAGAGCTATT-
GACGCG)). Full length cDNAs were amplified using specific
primers (Asu-unc-38 CTGCATTTATTAAGATGTTTGG and
ATGTAAATTATTGAGTGACTGG; Asu-unc-29 CACTGA-
GGGCAGTTATGCACC and CAGTGTGGGCGAGATAT-
TAGATC). Full length cDNAs were cloned into pGEM-T
(Promega) and transformed into XL-1 blue competent cells
(Stratagene).
Immunofluorescence
Antisera were raised, in rabbit and goat respectively, against
subunit-specific N-terminal peptides from Asu-UNC-38 and Asu-
UNC-29 (Harlan, UK and Sigma-Genosys, USA) then antibodies
were affinity purified as described [35]. Adult A. suum collected
from a local abattoir were kindly supplied by Professor Aaron
Maule and Emma Kidd from Queen’s University, Belfast. Muscle
cells were prepared by collagenase digestion [36] fixed and
antibody labelled [37]. Muscle cell preparations were then
mounted on slides and viewed using a Zeiss 510 confocal laser
scanning microscope.
Oocyte expression and electrophysiology
A. suum unc-38 and unc-29 cDNAs were sub-cloned into the
expression vector pT7TS (obtained from P. Krieg, University of
Texas, Addgene plasmid 17091), containing 59 and 39 untranslat-
ed regions from Xenopus b-globin. Plasmids were linearised, and
then used as template for cRNA synthesis using the T7 mMessage
mMachine kit (Ambion, UK). Oocytes were obtained from
EcoCyte Biosciences, Germany. Oocytes were injected with
nicotinic receptor cRNAs in RNAse-free water in a total volume
of 50 nl, which was the same for all experiments. When a single
cRNA species was injected, 25 ng was used; when both Asu-unc-29
and Asu-unc-38 cRNAs were injected, a total of 50 ng was used.
Oocyte injection was carried out using a Drummond ‘Nanoject’
microinjector and electrophysiological experiments were carried
out [38] using a GeneClamp 500 amplifier and Digidata 1322A
(Axon Instruments) with oocytes being voltage-clamped at
260 mV. Pharmacological compounds were obtained from
Sigma. Data was recorded and responses measured using pClamp
software. GraphPad Prism software was used to analyse the data
and fit sigmoid dose-response curves to the equation I/Imax=
Figure 6. Possible combinations of the two subunits in the oocyte membrane. The possible combination of Asu-UNC-38 and Asu-UNC-29
that might be present in the injected oocytes are shown. Agonist binding sites, which, by analogy with mammalian receptors should be at an
interface between the two subunits, [38] are indicated by black circles. The Figure is based on a similar discussion for mammalian receptors [32].
doi:10.1371/journal.ppat.1000517.g006
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(Imax2Imin/[1+10(logEC502[ag]*nH)])6Imax. For pyrantel and oxantel,
the equation was fitted to the data obtained for the rising phase of
the response only.
Accession numbers
The Accession numbers for proteins mentioned in the text are:
C. elegans: UNC-38 – Q23022, UNC-29 –P48181, UNC-63 –
Q9N587, ACR-12 – Q9GQU9, ACR-8 – Q23355, ACR-6 –
Q9N4M3, LEV-1 – P48181, ACR-3 – Q93149, ACR-2 –
P48182, ACR-16 – P48180. B. malayi: BM_UNC-29 –
Bm1_35890.
Acknowledgments
We thank Aaron Maule and Emma Kidd, Queen’s University, Belfast, for
supplying adult Ascaris suum, and Andrew Jones and Steve Buckingham,
MRC FGU, for helpful discussions. We should also like to thank the
referees and editors for their constructive and helpful comments on the first
version of this manuscript.
Author Contributions
Conceived and designed the experiments: SMW APR TW DJW RM DS
AJW. Performed the experiments: SMW APR. Analyzed the data: SMW
LB DS. Contributed reagents/materials/analysis tools: APR LB RM.
Wrote the paper: SMW DJW RM DS AJW.
References
1. Crompton DW (2001) Ascaris and ascariasis. Adv Parasitol 48: 285–375.
2. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, et al. (2006) Soil-
transmitted helminth infections: ascariasis, trichuriasis and hookworm. Lancet
367: 1521–1532.
3. Le Hasran JY, Akiana J, Ndiaye el HM, Dia M, Senghor P, et al. (2004) Severe
malaria attack is associated with high prevalence of Ascaris lumbricoides infection
among children in rural Senegal. Trans Roy Soc Trop Med Hyg 98: 397–399.
4. Fincham JE, Markus MB, Adams VJ (2003) Could control of soil-transmitted
helminthic infections influence the HIV/AIDS pandemic? Acta Trop 86:
315–333.
5. Stewart TB, Hale OM (1988) Losses to internal parasites in swine production.
J Anim Sci 66: 1548–1554.
6. Nejsum P, Parker ED Jr, Frydenburg J, Roepstorff A, Boes J, et al. (2005)
Ascariasis is a zoonosis in Denmark. J Clin Microbiol 43: 1142–1148.
7. Boes J, Helwigh AB (2000) Animal models of intestinal nematode infections of
humans. Parasitology 121: S97–S111.
8. Harrow ID, Gration AF (1985) Mode of action of the anthelmintics morantel,
pyrantel and levamisole on muscle cell membrane of the nematode Ascaris sum.
Pestic Sci 16: 662–672.
9. Kaminsky R, Ducray P, Jung M, Clover R, Rufener L, et al. (2008) A new class
of anthelmintics effective against drug-resistant nematodes. Nature 452:
176–180.
10. Levandowski MM, Robertson AP, Kuiper S, Qian H, Martin RJ (2005) Single-
channel properties of N- and L-subtypes of acetylcholine receptor in Ascaris suum.
Int J Parasitol 35: 925–934.
11. Martin RJ, Clark CL, Trailovic SM, Robertson AP (2004) Oxantel is an N-type
(methyridine and nicotine) agonist not an L-type (levamisole and pyrantel)
agonist: classification of cholinergic anthelmintics in Ascaris. Int J Parasitol 34:
1083–1090.
12. Qian H, Martin RJ, Robertson AP (2006) Pharmacology of N-, L-, and B-
subtypes of nematode nAChR resolved at the single-channel level in Ascaris suum.
FASEB J 20: 2606–2608.
13. Lewis JA, Wu CH, Berg H, Levine JH (1980) The genetics of levamisole
resistance in the nematode C. elegans. Genetics 95: 905–928.
14. Culetto E, Baylis HA, Richmond JE, Jones AK, Fleming JT, et al. (2004) The
Caenorhabditis elegans unc-63 gene encodes a levamisole-sensitive nicotinic
acetylcholine receptor alpha subunit. J Biol Chem 279: 42476–42483.
15. Fleming JT, Squire MD, Barnes TM, Tornoe C, Matsuda K, et al. (1997)
Caenorhabditis elegans levamisole resistance genes lev-1, unc-29, and unc-38 encode
functional nicotinic acetylcholine receptor subunits. J Neurosci 17: 5843–5857.
16. Towers PR, Edwards B, Richmond JE, Sattelle DB (2005) The Caenorhabditis
elegans lev-8 gene encodes a novel type of nicotinic acetylcholine receptor alpha
subunit. J Neurochem 93: 1–9.
17. Boulin T, Glelen M, Richmond JE, Williams DC, Paoletti P, et al. (2008) Eight
genes are required for functional reconstitution of the Caenorhabditis elegans
levamisole-sensitive acetylcholine receptor. Proc Natl Acad Sci USA 105:
18590–18595.
18. Miller D, von Stetina SE, Touroutine D, Fox R, Burdina AO, et al. (2005) ACR-
16 encodes an essential subunit of the levamisole-resistant nicotinic receptor at
the C. elegans neuromuscular junction. J Biol Chem 280: 27013–27021.
19. Blaxter ML, De Ley P, Garey JR, Liu LX, Scheldeman P, et al. (1998) A
molecular evolutionary framework for the phylum Nematoda. Nature 392:
71–75.
20. Ghedin E, Wang S, Spiro D, Caler E, Zhao Q, et al. (2007) Draft genome of the
filarial nematode parasite Brugia malayi. Science 317: 1756–1760.
21. Williamson SM, Walsh TK, Wolstenholme AJ (2007) The cys-loop ligand-gated
ion channel superfamily of Brugia malayi and Trichinella spiralis: a comparison with
Caenorhabditis elegans. Invert Neurosci 7: 219–226.
22. Laughton DL, Amar M, Thomas P, Towner P, Harris P, et al. (1994) Cloning of
a putative inhibitory amino acid receptor subunit from the parasitic nematode
Haemonchus contortus. Receptors Channels 2: 155–163.
23. Celie PH, van Rossum-Fikkert SE, van Dijk WJ, Nrejc K, Smit AB, et al. (2004)
Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as
studied in AChBP crystal structures. Neuron 41: 907–914.
24. Rayes D, De Rosa MJ, Bartos M, Bouzat C (2004) Molecular Basis of the
Differential Sensitivity of Nematode and Mammalian Muscle to the Anthel-
mintic Agent Levamisole. J Biol Chem 279: 36372–36381.
25. Rosenbluth J (1965) Ultrastructure of somatic muscle cells in Ascaris lumbricoides.
II. Intermuscular junctions, neuromuscular junctions and glycogen stores. J Cell
Biol 26: 579–591.
26. Colquhoun L, Holden-Dye L, Walker RJ (1991) The pharmacology of
cholinoceptors on the somatic muscle cells of the parasitic nematode Ascaris
suum. J Exp Biol 158: 509–530.
27. Moroni M, Zwart R, Sher E, Cassels BK, Bermudez I (2006) a4b2 nicotinic
receptors with high and low acetylcholine sensitivity: pharmacology, stoichiom-
etry and sensitivity to long-term exposure to nicotine. Mol Pharmacol 70:
755–768.
28. Tapia L, Kuryatov A, Lindstrom J (2007) Ca2+ permeability of the (a4)3(b2)2
stoichiometry greatly exceeds that of the (a4)2(b2)3 human acetylcholine
receptors. Mol Pharmacol 71: 769–776.
29. Dale VM, Martin RJ (1995) Oxantel-activated single channel currents in the
muscle membrane of Ascaris suum. Parasitology 110: 437–448.
30. Jones AK, Sattelle DB (2008) The cys-loop ligand-gated ion channel gene
superfamily of the nematode Caenorahbditis elegans. Invert Neurosci 8: 41–47.
31. Walker RJ, Colquhoun LM, Parri HR, Williams RG, Holden-Dye L (1992)
Pharmacology of the Ascaris nervous system. In: Duce IR, ed. Neurotox ’91:
Molecular basis of drug and pesticide action. London: Elsevier Applied Science.
pp 105–121.
32. Zwart R, Vijverberg HPM (1998) Four pharmacologically distinct subtypes of
a4b2 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes. Mol
Pharmacol 54: 1124–1131.
33. Kuryatov A, Onksen J, Lindstrom J (2008) Roles of accessory subunits in a4b2(*)
nicotinic receptors. Mol Pharmacol 74: 132–143.
34. Kopp SR, Coleman GT, Traub RJ, McCarthy JS, Kotze AC (2009)
Acetylcholine receptor subunit genes from Ancylostoma caninum: Altered
transcription patterns associated with pyrantel resistance. Int J Parasitol 39:
435–441.
35. Delany NS, Laughton DL, Wolstenholme AJ (1998) Cloning and localisation of
an avermectin receptor-related subunit from Haemonchus contortus. Mol Biochem
Parasitol 97: 177–187.
36. Johnson CD, Stretton AO (1987) GABA-immunoreactivity in inhibitory motor
neurons of the nematode Ascaris. J Neurosci 7: 223–235.
37. Brownlee DJ, Fairweather I, Johnston CF (1993) Immunocytochemical
demonstration of neuropeptides in the peripheral nervous system of the
roundworm Ascaris suum (Nematoda, Ascaroidea). Parasitol Res 79: 302–308.
38. Buckingham SD, Pym L, Sattelle DB (2006) Oocytes as an expression system for
studying receptor/channel targets of drugs and pesticides. Methods Mol Biol
322: 331–345.
39. Changeux J-P, Taly A (2008) Nicotinic receptors, allosteric proteins and
medicine. Trends Mol Med 14: 93–102.
40. Corringer P-J, Bertrand S, Galzi J-L, Devillers-Thiery A, Changeux J-P, et al.
(1999) Mutational analysis of the charge selectivity filter of the a7 nicotinic
acetylcholine receptor. Neuron 22: 831–843.
Nicotinic Receptors of Ascaris suum
PLoS Pathogens | www.plospathogens.org 11 July 2009 | Volume 5 | Issue 7 | e1000517
